Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects

Objective: In obese men, the increased expression of the aromatase enzyme in adipose tissue leads to high conversion of androgens to estrogens contributing to hypogonadotropic hypogonadism (HHG). Our objective is to evaluate efficacy and safety of weight loss (WL) plus aromatase inhibitor (AI) thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Endocrinol (Lausanne)
Main Authors: Colleluori, Georgia, Chen, Rui, Turin, Christie G., Vigevano, Francesca, Qualls, Clifford, Johnson, Biju, Mediwala, Sanjay, Villareal, Dennis T., Armamento-Villareal, Reina
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243137/
https://ncbi.nlm.nih.gov/pubmed/32499757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00277
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados